Publicacións en colaboración con investigadores/as de Hospital San Agustin (25)

2024

  1. Analysis of the Evolution of Tuberculosis in Men and Women in Spain Between 2017 and 2022. Is There a Different Incidence Decline by Gender?

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 312-315

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

  2. Study of the Diagnostic Delay of Tuberculosis in Spain

    Archivos de Bronconeumologia

2020

  1. Evaluation of the Integrated Tuberculosis Research Program Sponsored by the Spanish Society of Pulmonology and Thoracic Surgery: 11 Years on

    Archivos de Bronconeumologia, Vol. 56, Núm. 8, pp. 483-492

  2. Study of the Diagnostic Delay of Tuberculosis in Spain

    Archivos de Bronconeumologia

2019

  1. Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

    Liver International, Vol. 39, Núm. 1, pp. 90-97

2017

  1. Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection

    Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237

  2. Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study

    Respiratory Medicine, Vol. 132, pp. 68-75

  3. Quorum sensing network in clinical strains of A. baumannii: AidA is a new quorum quenching enzyme

    PLoS ONE, Vol. 12, Núm. 3

  4. Response to bile salts in clinical strains of Acinetobacter baumannii lacking the adeABC efflux pump: Virulence associated with quorum sensing

    Frontiers in Cellular and Infection Microbiology, Vol. 7, Núm. MAY

2016

  1. Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection

    Archivos de Bronconeumologia, Vol. 52, Núm. 9, pp. 477-481

  2. Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 304-308

  3. Factors associated with fatality during the intensive phase of anti-tuberculosis treatment

    PLoS ONE, Vol. 11, Núm. 8

  4. Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 34, Núm. 5, pp. 303.e1-303.e13

  5. Spanish Compliance With Guidelines for Prescribing Four Drugs in the Intensive Phase of Standard Tuberculosis Treatment

    Archivos de Bronconeumologia, Vol. 52, Núm. 5, pp. 262-268

  6. Tuberculosis Costs in Spain and Related Factors

    Archivos de Bronconeumologia, Vol. 52, Núm. 12, pp. 583-589

2014

  1. Epidemiologic and clinical impact of acinetobacter baumannii colonization and infection: A reappraisal

    Medicine (United States), Vol. 93, Núm. 5, pp. 202-210

2013

  1. Corkscrew-like hair and perifollicular purpura as a vitamin C deficiency sign

    Medicina Clinica, Vol. 141, Núm. 11

2012

  1. A predictive scoring instrument for tuberculosis lost to follow-up outcome

    Respiratory Research, Vol. 13